Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,583 | 6 | 66.1% |
| Food and Beverage | $3,101 | 69 | 16.3% |
| Consulting Fee | $2,680 | 1 | 14.1% |
| Travel and Lodging | $397.52 | 3 | 2.1% |
| Education | $262.80 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $13,948 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,952 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $400.80 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $245.13 | 2 | $0 (2024) |
| Seagen Inc. | $198.88 | 4 | $0 (2023) |
| Exelixis Inc. | $162.17 | 1 | $0 (2023) |
| Telix Pharmaceuticals | $129.91 | 1 | $0 (2024) |
| GENZYME CORPORATION | $102.86 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $95.00 | 1 | $0 (2022) |
| AVEO Pharmaceuticals, Inc. | $91.05 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,222 | 39 | Gilead Sciences, Inc. ($13,623) |
| 2023 | $1,384 | 30 | Gilead Sciences, Inc. ($325.10) |
| 2022 | $344.79 | 10 | SANOFI-AVENTIS U.S. LLC ($95.00) |
| 2021 | $72.77 | 4 | Alexion Pharmaceuticals, Inc. ($20.56) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| 12/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: ONC | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $58.71 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: ONC | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $68.52 | General |
| 12/10/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $41.30 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
| 09/26/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $129.91 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/10/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $138.02 | General |
| Category: ONC | ||||||
| 09/06/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: ONC | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: ONC | ||||||
| 08/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.52 | General |
| 08/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: ONC | ||||||
| 08/08/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO, KISQALI | Food and Beverage | In-kind items and services | $49.71 | General |
| Category: Oncology | ||||||
| 08/08/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| 08/01/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $166.06 | General |
| Category: ONC | ||||||
| 08/01/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: ONC | ||||||
| 07/23/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: ONC | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $116.66 | General |
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $42.00 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $122.45 | General |
| Category: ONC | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.64 | General |
| 06/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 05/21/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $337.50 | General |
| Category: ONC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $2,640 | $1,079 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $2,640 | $1,079 | 40.9% |
About Dr. Matthew Kurian, MD
Dr. Matthew Kurian, MD is a Hematology & Oncology healthcare provider based in Edgewood, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1174054548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Kurian, MD has received a total of $19,024 in payments from pharmaceutical and medical device companies, with $17,222 received in 2024. These payments were reported across 83 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,583).
As a Medicare-enrolled provider, Kurian has provided services to 11 Medicare beneficiaries, totaling 11 services with total Medicare billing of $1,079. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Edgewood, KY
- Active Since 03/27/2017
- Last Updated 06/20/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1174054548
Products in Payments
- Trodelvy (Drug) $13,944
- OPDIVO (Biological) $245.13
- KISQALI (Drug) $189.59
- CABOMETYX (Drug) $162.17
- ILLUCCIX (Drug) $129.91
- TUKYSA (Drug) $106.77
- JEVTANA (Drug) $95.00
- FOTIVDA (Drug) $91.05
- Orserdu (Drug) $78.76
- GILOTRIF (Drug) $67.80
- Nubeqa (Drug) $51.27
- LUTATHERA (Drug) $49.71
- TAGRISSO (Drug) $42.00
- ERLEADA (Drug) $40.31
- EXKIVITY (Drug) $31.13
- PADCEV (Biological) $24.98
- AYVAKIT (Drug) $23.13
- PEMAZYRE (Drug) $23.05
- IMBRUVICA (Drug) $22.50
- PYLARIFY (Drug) $21.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Edgewood
Manish Bhandari, M.d, M.D
Hematology & Oncology — Payments: $5,188
Dr. Lawrence Brennan, Md, MD
Hematology & Oncology — Payments: $2,745
Daniel Flora, M.d, M.D
Hematology & Oncology — Payments: $1,416
Dr. Douglas Flora, Md, MD
Hematology & Oncology — Payments: $1,218
Christy Sapp, M.d, M.D
Hematology & Oncology — Payments: $647.20
Dr. John Winkelmann, Md, MD
Hematology & Oncology — Payments: $198.00